Clinical trials
Completed Dysentery trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2 |
| Centre for Infectious Disease Research in Zambia | 2 |
| Genzyme, a Sanofi Company | 2 |
| Abdul Latif Jameel Poverty Action Lab | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Cosmo Technologies Ltd | 1 |
| Council for Scientific and Industrial Research, South Africa | 1 |
| Daniel Leung | 1 |
| Eskisehir Osmangazi University | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dysentery | 28 |
| Diarrhea | 14 |
| Dysentery, Bacillary | 8 |
| Enterocolitis, Pseudomembranous | 2 |
| Gastrointestinal Diseases | 2 |
| Arthritis, Reactive | 1 |
| Asthma | 1 |
| Bacterial Infections | 1 |
| Campylobacter Infections | 1 |
| Clostridium Infections | 1 |
Trials
Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.